Sanofi and Orano join forces to develop next-generation radioligand medicines Paris, . Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development ...

Paris, October 11, 2024. Sanofi today announces that the company has entered into negotiations with CD&R for the potential sale of a 50% controlling stake in Opella, its consumer healthcare business.

Paul Hudson is reshaping Sanofi into a modern healthcare company with the ambition to transform the practice of medicine. Paul and the Sanofi teams are focusing efforts to discover, develop, ...

Third quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session. We’re proud to be premium ...

Communiqué de presse : Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d’un myélome multiple nouvellement ...

We chase the miracles of science to improve people’s lives. But we can’t do it alone. We work closely with healthcare professionals, patient advocates, governments and industry so we can have the ...

We chase the miracles of science to improve people’s lives, and sometimes that means starting over with Plan B, Plan C, or even Plan Z. This film brings together the inner thoughts and ambitions of ...

Our incredibly talented, creative scientists dig into a rich toolbox of technologies to develop smart, safe, effective medicines and vaccines that break the mold. Our integrated genomic medicine unit ...

We want to build a healthier, more resilient world. We turn the impossible into the possible by discovering, developing, and delivering medicines and vaccines for millions of people around the world.

Edistymisemme yhdistää meidät ja saa meidät kasvamaan, oppimaan ja ylittämään yhdessä rajojamme. Mitä tarkoitamme tieteen ihmeillä? Meille se merkitsee lääketieteellisiä läpimurtoja, jotka helpottavat ...

The www.sanofi.com website (hereinafter the “site”) is owned and operated by SANOFI WINTHROP INDUSTRIE, belonging to Groupe Sanofi. The presentation and each of the elements, including trademarks, ...

At Sanofi, we strive to provide better health and access to quality medicines and vaccines around the world for patients and populations who need them. We share this responsibility with various actors ...